San Francisco

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Gastric and oesophageal cancer1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial

Status

• Completed3 trials

Lead sponsor

• Bristol-Myers Squibb3 trials

Closed trials

• Completed

  An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread

  NCT03377361· Phase 1/2· Bristol-Myers Squibb· Source

• Completed

  Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

  NCT02872116· Phase 3· Bristol-Myers Squibb· Source

• Completed

  A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread

  NCT02060188· Phase 2· Bristol-Myers Squibb· Source